SEHK:2268Life Sciences
WuXi XDC Cayman (SEHK:2268) Gains Overseas GMP Release, Is The Stock Fully Priced?
WuXi XDC Cayman (SEHK:2268) has reached a new phase in its international build out with its BCM3 dual function production line in Singapore receiving GMP release and moving into global commercial manufacturing.
See our latest analysis for WuXi XDC Cayman.
Against this backdrop, WuXi XDC Cayman's momentum has been strong, with a 30 day share price return of 28.75% and a year to date share price return of 16.79%. This has contributed to a 1 year total shareholder return of 24.18% at a latest...